Jam

HNI Corporation is progressing its $5.7 billion acquisition of Steelcase by launching an exchange offer for Steelcase’s 5.125% notes due 2029. Eligible holders can exchange notes for new HNI notes (up to $450M). Early tenders (by Oct 9, 2025) receive $1,000 in new notes plus $2.50 cash per $1,000 principal; later tenders receive $970. The HNI notes will be secured, unlike the Steelcase notes. The acquisition, targeted for Q4 2025 closing, isn’t contingent on the offer’s success. The exchange offer expires October 27, 2025.

On September 26, 2025, Shell plc repurchased 948,416 shares across multiple exchanges as part of its ongoing buyback program announced on July 31, 2025. 499,035 shares were bought on the LSE and associated platforms (price range: £27.0850-£27.3900) and 449,381 shares on European exchanges (price range: €31.1100-€31.5200). HSBC Bank plc manages the program independently, adhering to UK and EU regulations. The buyback, slated to continue until October 24, 2025, aims to enhance shareholder value.

Transwestern Pipeline, a subsidiary of Energy Transfer LP, announced an open season (Sept 26-Oct 25, 2025) for an expansion of its natural gas pipeline across TX, NM, and AZ. The Desert Southwest expansion aims to transport at least 1.5 Bcf/d of Permian Basin natural gas to markets in the Southwest, anticipating increased demand. Sufficient commitments exist, but additional commitments will optimize the project, targeting Q4 2029 operation, pending regulatory approvals. The expansion addresses Permian takeaway capacity constraints but faces environmental and economic challenges.

Sify Infinit Spaces Limited (SISL), a Sify Technologies subsidiary, has received board approval for a potential IPO of equity shares in India. The IPO aims to fund data center expansion amid growing demand for colocation services. The offering is restricted to the Indian market and will not be registered under the U.S. Securities Act of 1933, precluding U.S. investors. SISL currently operates 14 data centers across 6 cities in India.

Soligenix, Inc. (SNGX) announced a public offering of 5,555,560 shares of common stock (or equivalents) with warrants at $1.35 per share/warrant. The warrants are immediately exercisable at $1.35, expiring in five years. Existing warrants for 1,162,064 shares will be amended to the same price and expiration. The offering, expected to close around September 29, 2025, aims to raise $7.5 million, which will fund R&D, commercialization, and general corporate needs. A.G.P./Alliance Global Partners is the sole placement agent. This offering is under an effective SEC registration statement.

Aker Carbon Capture (AKRCY) will distribute a liquidation dividend of NOK 0.141 per share, totaling NOK 85,198,152.738, following shareholder approval on August 5, 2025. Key dates include an ex-dividend date of October 3, 2025, and payment around October 13, 2025. The move raises questions about the company’s future and the viability of standalone carbon capture ventures, potentially signaling consolidation within the industry. The fate of Aker Carbon Capture’s technology and projects remains uncertain.

CSL Vifor and Travere Therapeutics acknowledge the updated KDIGO 2025 guidelines for IgA Nephropathy (IgAN). These guidelines refine diagnostic criteria, treatment goals, and therapeutic approaches for this leading cause of kidney failure. Notably, FILSPARI® (sparsentan), a Dual Endothelin Angiotensin Receptor Antagonist (DEARA), is highlighted as a potential first-line treatment option for managing IgAN-induced nephron loss, contrasting the traditional RASi-first approach. The guidelines cite the PROTECT trial, demonstrating FILSPARI’s efficacy compared to optimized RASi therapy. Experts believe the updated guidance will improve treatment decisions and long-term kidney outcomes.

Mirion Technologies (NYSE: MIR) announced the pricing of an upsized public offering of 17.3 million shares of Class A common stock at $21.35 per share, aiming to raise approximately $356.2 million. Simultaneously, they priced a $325 million convertible senior notes offering. Proceeds will fund capped call transactions related to the notes and the acquisition of Paragon Energy Solutions. The offerings are expected to close on September 30, 2025. Goldman Sachs and Evercore ISI are leading the common stock offering. These moves support Mirion’s growth strategy in radiation safety, science, and medicine.

CenterPoint Energy (CNP) declared a regular quarterly cash dividend of $0.2200 per share, payable December 11, 2025, to shareholders of record on November 20, 2025. Analysts view the consistent dividend as a sign of financial health amidst industry transformation. While reassuring to investors, the company faces challenges related to renewable energy integration, grid modernization, and capital expenditures. CenterPoint’s long-term success hinges on its ability to execute modernization plans, maintain operational efficiency, and adapt to evolving customer demands across its multi-state service territories.

Wellgistics Health (WGRX) announced a $5 million public offering of 7,142,862 shares and warrants priced at $0.70 per share. Warrants are exercisable at $0.70 immediately and expire in five years. The offering, managed by H.C. Wainwright & Co., is expected to close around September 29, 2025. Proceeds will fund working capital, operating expenses, R&D, and potential acquisitions. The offering entails significant shareholder dilution.